Search Results
Mar 20, 2026, 08:00 ET HONEYWELL ANNOUNCES EARLY PARTICIPATION RESULTS AND UPSIZING OF ITS DEBT TENDER OFFERS
to meet the conditions related thereto; (ii) the possibility that the Spin-Off will not be completed within the anticipated time period or at all; (iii) the possibility that the Spin-Off will not achieve its intended benefits; (iv) the impact of the Spin-Off on Honeywell's and Aerospace's businesses
More news about: Honeywell
Mar 20, 2026, 05:06 ET Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
studies in gastric cancer underway, positioning upcoming data as a potential key value inflection point. The company plans to initiate a pivotal Phase III monotherapy trial in gastric cancer in 2026, with enrollment starting in the second half of 2026. ATG-037 (oral CD73 small molecule inhibitor)
More news about: Antengene Corporation Limited
Mar 20, 2026, 05:00 ET XPENG Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
quarter, under the agreement entered into with the Manufacturer; (ii) parts and accessories sales in line with higher accumulated vehicle sales; and (iii) carbon credit trading. Cost of sales was RMB17.51 billion (US$2.50 billion) for the fourth quarter of 2025, representing an increase
More news about: XPeng Inc.
Mar 20, 2026, 04:23 ET El Grupo Praana avanza en su expansión estratégica con el nombramiento de Darpan Parikh
ampliando así sus capacidades en el ambito de los productos químicos especializados en los mercados energéticos e industriales.(iii) con Arkema para la propuesta de adquisición de la planta de producción de Vlissingen en los Países Bajos y los negocios relacionados con aditivos plásticos,
More news about: Praana Group
Mar 20, 2026, 04:17 ET Le groupe Praana poursuit son expansion stratégique avec la nomination de Darpan Parikh
permettra d'étendre ses capacités dans le domaine des produits chimiques spécialisés sur les marchés de l'énergie et de l'industrie.(iii) avec Arkema, avec la proposition d'acquisition de l'usine de production de Vlissingen aux Pays-Bas et des activités liées aux additifs plastiques, y
More news about: Praana Group
Mar 20, 2026, 00:30 ET Anjarle: An Elevated Horizon by the Arabian Sea
both rental and ownership.The Supply Constraint: Structural, Permanent, UnresolvableCoastal Regulation Zone III (CRZ-III) norms prohibit all development within 200 metres of the high tide line and tightly restrict the 200–500 metre band beyond. Anjarle's designation
More news about: Liases Foras Real Estate Rating & Research Pvt Ltd
Mar 19, 2026, 21:54 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Gemini Space Station, Inc. and Certain Officers - GEMI
platform; (ii) Gemini had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, Gemini's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that Gemini
More news about: Pomerantz LLP
Mar 19, 2026, 20:09 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
of the case: According to the lawsuit, defendants provided investors with material information concerning Ultragenyx's expected results for its Phase III Orbit and Cosmic Studies, which tested setrusumab (UX 143) in patients with Osteogenesis Imperfecta ("OI"). Defendants' statements included, among other
More news about: THE ROSEN LAW FIRM, P. A.
Mar 19, 2026, 19:45 ET Samsonite Group S.A. Announces Results for the Year Ended December 31, 2025
which resulted in a cash outflow, year-over-year, (ii) an increase in principal payments on lease liabilities, year-over-year, partially offset by (iii) a decrease in capital expenditures in 2025, year-over-year.Under our share buyback program, which we completed on March 28, 2025, we repurchased
More news about: Samsonite
Mar 19, 2026, 18:12 ET CRE Finance Council Announces Planned Retirement of President & CEO Lisa Pendergast
strengthened its role as the commercial real estate finance industry's central forum for dialogue, advocacy, and market intelligence," said Leland F. Bunch III, Managing Director at Bank of America and the Chair of CREFC's Executive Committee and Board of Governors. "The Board has launched a thoughtful and thorough
More news about: CRE Finance Council
Mar 19, 2026, 16:45 ET INVESTOR DEADLINE: Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action
mitigate effects arising from the termination of the Residential Clean Energy Credit pursuant to Internal Revenue Code Section 25D (the "25D Credit"); and (iii) accordingly, Enphase Energy overstated its financial and operational prospects.The Enphase Energy class action lawsuit further alleges
More news about: Robbins Geller Rudman & Dowd LLP
Mar 19, 2026, 16:42 ET LEMAY - AMERICA'S CAR MUSEUM INTRODUCES WORLD'S FIRST NEXT-GENERATION RACING SIMULATORS
LeMay – America's Car Museum becomes the first in the world to feature the new CXC MP3 Motion Pro III racing simulatorsPowered by Assetto Corsa professional racing simulation software for ultra-realistic racing dynamicsAvailable now for museum guests and private
More news about: America's Automotive Trust
Mar 19, 2026, 16:30 ET A1R water and Inflection Point Acquisition Corp. III Announce Upsizing of PIPE Investment to $83.5 Million
MIAMI, March 19, 2026 /PRNewswire/ -- A1R water and Inflection Point Acquisition Corp. III (Nasdaq: IPCX) ("Inflection Point") today announced a significant expansion of their previously disclosed PIPE, increasing total commitments to approximately
More news about: Air Water Ventures Holdings Ltd.
Mar 19, 2026, 16:06 ET Institute for Supply Management® Honors 2025 ISM® 30 Under 30 Rising Supply Chain Stars
Ewing, principal associate, third-party manager, technology, Capital One (Washington, D.C.)Bergin Finn, global sourcing specialist III, Boston Scientific (Minneapolis)Deflah Komen, procurement lead, AGC Tenwek Hospital – Cardiothoracic Center (Nairobi County, Kenya)Alisa
More news about: Institute for Supply Management
Mar 19, 2026, 16:00 ET Ziegler Closes $30,000,000 Financing for Butterfield Trail Village
construction of a new assisted living facility with 38 units; (ii) conversion of the existing assisted living center into seven new independent living units; (iii) new office space for the marketing and business office teams; (iv) $11.2 million of past capital expenditures for 2025 and future capital expenditures
More news about: Ziegler
Mar 19, 2026, 16:00 ET Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
outstanding common stock, warrants, and stock options, (ii) the extinguishment of the Company's outstanding debt which was assumed by the Acquirer, (iii) assets and liabilities related to the Inhibrx 101 Business, which were assumed by the Acquirer, and (iv) transaction costs paid for by the Acquirer.Net
More news about: Inhibrx Biosciences, Inc.
Mar 19, 2026, 13:30 ET T. ROWE PRICE AND OAK HILL ADVISORS LAUNCH MULTI-STRATEGY CREDIT INTERVAL FUND "OFLEX" FOR U.S. WEALTH CLIENTS
applicable laws and regulations, (ii) do not and cannot replace the offering documents and is qualified in its entirety by the offering documents, and (iii) may not be relied upon in making an investment decision related to any investment offering by the issuer of the securities, or any affiliate, or partner
More news about: T. Rowe Price Group
Mar 19, 2026, 13:13 ET Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million
Series B warrants (the "Series B Warrants") to purchase up to 85,101,201 shares of the Company's common stock, par value $0.0001 ("Common Stock") and (iii) Series C warrants (the "Series C Warrants") to purchase up to 85,101,201 shares of Common Stock, (the Series B Warrants together with the Series C Warrants,
More news about: Azitra, Inc.
Mar 19, 2026, 13:00 ET Finalists Announced for the 2026 NVTC Tech CFO Awards
Mutryn, MaximusTransformative CFO of the Year:Michael Armstrong, Tharros Defense Inc.John McMonagle III, UnanetPamela Rothka, Empower AIJohn Rucker, CarbyneSabrina Stover, NeumoClass of Rising Stars:
More news about: Northern Virginia Technology Council
Mar 19, 2026, 12:12 ET FIBRA Prologis Anuncia Asamblea Ordinaria de Tenedores
Acciones y resoluciones al respecto.III.Propuesta, discusión y, en su caso, ratificación,
More news about: FIBRA Prologis
Mar 19, 2026, 12:11 ET FIBRA Prologis Anuncia Asamblea Ordinaria de Tenedores
Acciones y resoluciones al respecto.III.Propuesta, discusión y, en su caso, ratificación,
More news about: FIBRA Prologis
Mar 19, 2026, 12:00 ET Unlikely Collaborators Hosts Peabody Award-Winning Broadcaster and Author Krista Tippett
artists, and collaborators for conversations that challenge perspectives and deepen connections. Past Spark Salon speakers have included illusionist Harris III, psychologist Scott Barry Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author
More news about: Unlikely Collaborators
Mar 19, 2026, 10:42 ET FIBRA Prologis Announces an Ordinary Certificate Holders Meeting
Actions and resolutions in this regard.III. Proposal, discussion and, where appropriate,
More news about: FIBRA Prologis
Mar 19, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
action]On March 13, 2026, Immutep issued a press release "announc[ing] that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1st line non-small cell lung cancer has recommended the discontinuation of the trial
More news about: Pomerantz LLP
Mar 19, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines - RARE
$10.41 per share, or 25.11%, to close at $31.04 per share on July 10, 2025. Then, on December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had failed to "achieve statistical significance against the primary endpoints of reduction in annualized clinical fracture rate
More news about: Pomerantz LLP